Biosimilars

Biosimilars

Driving to lowest net cost means keeping all options in mind
Read the briefing →
Proactive monitoring and innovative strategies needed to mitigate costs
Read the briefing →
Drugs in the pipeline to treat ophthalmic disorders include biosimilars and novel treatments
Read the briefing →
Interpretation and analysis of marketplace trends including a robust drug development pipeline, transformative therapies and the growing importance of biosimilars; and implications for plan sponsors
Read the briefing →
CVS Health offers strategies for addressing new-to-market products to ensure access to clinically appropriate insulin or other medications.
Read the commentary →